Purchases and Sales Made in Q4 2022 in Apellis Pharmaceuticals, Inc. (APLS)
This table provides information about the institutional ownership of Apellis Pharmaceuticals, Inc. (APLS) during Q4 2022. The information is specifically focused on institutions that hold shares of Apellis Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2023
Q4 2022
|
Sei Investments CO
Oaks, PA |
SELL
|
- |
-45.1K- 80.69% |
$1.95M - $2.75M
|
10.8K
$206K
|
|
|
Feb 14, 2023
Q4 2022
|
Parallax Volatility Advisers, L.P.
San Francisco, CA |
SELL
|
- |
-45.3K- 58.68% |
$1.96M - $2.76M
|
31.9K
$609K
|
|
|
Jan 30, 2023
Q4 2022
|
New York State Common Retirement Fund
|
SELL
|
- |
-45.5K- 30.37% |
$1.97M - $2.78M
|
104K
$1.99M
|
|
|
Jan 12, 2023
Q4 2022
|
Hennion & Walsh Asset Management, Inc.
|
SELL
|
- |
-48.3K- 83.68% |
$2.09M - $2.95M
|
9.42K
$180K
|
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-49.7K- 12.1% |
$2.15M - $3.03M
|
361K
$6.89M
|
|
|
Feb 13, 2023
Q4 2022
|
Candriam S.C.A.
|
SELL
|
- |
-65K- 18.92% |
$2.81M - $3.97M
|
279K
$5.32M
|
|
|
Feb 14, 2023
Q4 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-68.3K- 80.64% |
$2.95M - $4.17M
|
16.4K
$313K
|
|
|
Feb 13, 2023
Q4 2022
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-100K- 10.0% |
$4.32M - $6.1M
|
900K
$17.2M
|
|
|
Feb 13, 2023
Q4 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-102K- 16.99% |
$4.43M - $6.25M
|
501K
$9.57M
|
|
|
Feb 03, 2023
Q4 2022
|
Lisanti Capital Growth, LLC
|
SELL
|
- |
-142K- 71.77% |
$6.12M - $8.64M
|
55.7K
$1.06M
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-158K- 45.7% |
$6.82M - $9.63M
|
187K
$3.58M
|
|
|
Feb 14, 2023
Q4 2022
|
Moore Capital Management, LP
New York, NY |
SELL
|
- |
-170K- 94.44% |
$7.35M - $10.4M
|
10K
$191K
|
|
|
Feb 14, 2023
Q4 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-184K- 93.46% |
$7.98M - $11.3M
|
12.9K
$246K
|
|
|
Feb 10, 2023
Q4 2022
|
Tekla Capital Management LLC
|
SELL
|
- |
-200K- 75.03% |
$8.63M - $12.2M
|
66.4K
$1.27M
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-223K- 32.21% |
$9.64M - $13.6M
|
469K
$8.96M
|
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-238K- 92.39% |
$10.3M - $14.5M
|
19.6K
$375K
|
|
|
Feb 09, 2023
Q4 2022
|
Victory Capital Management Inc
|
SELL
|
- |
-243K- 36.04% |
$10.5M - $14.8M
|
430K
$8.22M
|
|
|
Feb 13, 2023
Q4 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-305K- 53.65% |
$13.2M - $18.6M
|
263K
$5.03M
|
|
|
Feb 14, 2023
Q4 2022
|
Polar Asset Management Partners Inc.
Toronto, A6 |
SELL
|
- |
-324K- 84.76% |
$14M - $19.8M
|
58.3K
$1.11M
|
|
|
Feb 14, 2023
Q4 2022
|
Acuta Capital Partners, LLC
Belmont, CA |
SELL
|
- |
-337K- 60.74% |
$14.6M - $20.5M
|
218K
$4.15M
|
|
|
Jan 12, 2023
Q4 2022
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-498K- 40.61% |
$21.5M - $30.4M
|
728K
$13.9M
|
|
|
Feb 13, 2023
Q4 2022
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-542K- 54.87% |
$23.4M - $33.1M
|
446K
$8.51M
|
|
|
Feb 14, 2023
Q4 2022
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-565K- 65.79% |
$24.4M - $34.5M
|
294K
$5.61M
|
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-601K- 17.95% |
$26M - $36.7M
|
2.75M
$52.5M
|
|
|
Feb 13, 2023
Q4 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-1.2M- 12.05% |
$51.9M - $73.2M
|
8.76M
$167M
|